Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma

ClinicalTrials.gov ID: NCT00419757

Public ClinicalTrials.gov record NCT00419757. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 5:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-week, Randomised, Double Blind, Active-controlled, Multi-centre, Phase IIIB Study Comparing the Efficacy and Safety of SYMBICORT® pMDI 160/4.5 mg x 2 Actuations Twice Daily Versus Budesonide HFA pMDI 160 mg x 2 Actuations Twice Daily, in Adult/Adolescent (> 12 Yrs) Hispanic Subjects With Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the effectiveness and safety of SYMBICORT® pMDI (a medication approved by the Food and Drug Administration(FDA)) in the Hispanic population.

Study identification

NCT ID
NCT00419757
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
558 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2006
Primary completion
May 31, 2008
Completion
May 31, 2008
Last update posted
Aug 26, 2012

2007 – 2008

United States locations

U.S. sites
32
U.S. states
8
U.S. cities
32
Facility City State ZIP Site status
Research Site Anaheim California
Research Site Chula Vista California
Research Site Fresno California
Research Site Fullerton California
Research Site Los Angeles California
Research Site National City California
Research Site Rancho Cordova California
Research Site Rancho Mirage California
Research Site Riverside California
Research Site Sacramento California
Research Site San Diego California
Research Site San Francisco California
Research Site Stockton California
Research Site Torrance California
Research Site Pueblo Colorado
Research Site Largo Florida
Research Site Miami Florida
Research Site Naranja Florida
Research Site North Miami Florida
Research Site Orlando Florida
Research Site Panama City Florida
Research Site South Miami Florida
Research Site Chicago Illinois
Research Site Newburgh New York
Research Site Oklahoma City Oklahoma
Research Site Philadelphia Pennsylvania
Research Site Boerne Texas
Research Site El Paso Texas
Research Site Fort Worth Texas
Research Site Houston Texas
Research Site San Antonio Texas
Research Site Spring Texas

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00419757, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 26, 2012 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00419757 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →